全文获取类型
收费全文 | 4758篇 |
免费 | 305篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 139篇 |
妇产科学 | 113篇 |
基础医学 | 755篇 |
口腔科学 | 74篇 |
临床医学 | 467篇 |
内科学 | 939篇 |
皮肤病学 | 223篇 |
神经病学 | 574篇 |
特种医学 | 156篇 |
外科学 | 382篇 |
综合类 | 19篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 465篇 |
眼科学 | 76篇 |
药学 | 272篇 |
中国医学 | 17篇 |
肿瘤学 | 382篇 |
出版年
2024年 | 7篇 |
2023年 | 36篇 |
2022年 | 71篇 |
2021年 | 157篇 |
2020年 | 101篇 |
2019年 | 146篇 |
2018年 | 155篇 |
2017年 | 105篇 |
2016年 | 143篇 |
2015年 | 141篇 |
2014年 | 216篇 |
2013年 | 262篇 |
2012年 | 387篇 |
2011年 | 392篇 |
2010年 | 233篇 |
2009年 | 207篇 |
2008年 | 297篇 |
2007年 | 297篇 |
2006年 | 316篇 |
2005年 | 302篇 |
2004年 | 260篇 |
2003年 | 216篇 |
2002年 | 179篇 |
2001年 | 30篇 |
2000年 | 25篇 |
1999年 | 29篇 |
1998年 | 33篇 |
1997年 | 23篇 |
1996年 | 29篇 |
1995年 | 22篇 |
1994年 | 18篇 |
1993年 | 12篇 |
1992年 | 13篇 |
1991年 | 13篇 |
1990年 | 14篇 |
1989年 | 8篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 11篇 |
1985年 | 16篇 |
1984年 | 17篇 |
1983年 | 7篇 |
1981年 | 10篇 |
1977年 | 10篇 |
1975年 | 7篇 |
1974年 | 7篇 |
1973年 | 6篇 |
1972年 | 6篇 |
1971年 | 9篇 |
1968年 | 7篇 |
排序方式: 共有5082条查询结果,搜索用时 17 毫秒
71.
72.
Ellen Strijbos Martijn R. Tannemaat Iris Alleman Robert H.P. de Meel Jaap A. Bakker Ruud van Beek Frank P. Kroon Guus F. Rimmelzwaan Jan J.G.M. Verschuuren 《Vaccine》2019,37(7):919-925
Objective
To investigate the efficacy and safety of an influenza vaccination in patients with myasthenia gravis with acetylcholine receptor antibodies (AChR MG).Methods
An influenza vaccination or placebo was administered to 47 AChR MG patients. Before and 4?weeks after administration blood samples and clinical outcome scores were obtained. Antibodies to the vaccine strains A/California/7/2009 (H1N1)pdm09, A/Hong Kong/4801/14 (H3N2) and B/Brisbane/060/08 were measured using the hemagglutination-inhibition (HI) assay and disease-specific AChR antibody titers were measured with a radio-immunoprecipitation assay. Forty-seven healthy controls (HC) were vaccinated with the same influenza vaccine to compare antibody titers.Results
A post-vaccination, seroprotective titer (HI?≥?1:40) was achieved in 89.4% of MG patients vs. 93.6% in healthy controls for the H3N2 strain, 95.7% vs 97.9% for the H1N1 strain and 46.8 vs 51% for the B-strain. A seroprotective titer for all three strains of the seasonal influenza vaccine was reached in 40.4% (19/47) of the MG group and in 51% (24/47) of the HC group. Immunosuppressive medication did not significantly influence post geomean titers (GMT). The titers of disease-specific AChR antibodies were unchanged 4?weeks after vaccination. The clinical outcome scores showed no exacerbation of MG symptoms.Conclusion
The antibody response to an influenza vaccination in patients with AChR MG was not different from that in healthy subjects, even in AChR MG patients using immunosuppressive medication. Influenza vaccination does not induce an immunological or clinical exacerbation of AChR MG.Clinical trial registry
The influenza trial is listed on clinicaltrialsregister.eu under 2016-003138-26. 相似文献73.
74.
Dora Fabijanovic Iris Zunic Tamara Nikuseva Martic Faruk Skenderi Ljiljana Serman Semir Vranic 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2016,124(11):942-949
Germ cell tumors of the testis are a heterogeneous group of neoplasms that affect male adolescents and young adults. Wnt signaling pathway components have been shown to be actively involved in normal and malignant germ cell differentiation and progression. In this study, we aimed to explore the expression patterns of the secreted frizzled‐related protein (SFRP) and Disheveled protein family (DVL) in a subset of testicular germ cell tumors. Eighty‐five formalin‐fixed, paraffin‐embedded tissue samples of the primary germ cell tumors of the testis were stained against SFRP1, SFRP3, DVL1, and DVL2 proteins using immunohistochemistry. SFRP1 and SFRP3 exhibited lower expression in both seminomas and mixed/non‐seminomatous tumors, compared with atrophic/benign tissue (p < 0.001). SFRP3 expression was lower than SFRP1 expression within the seminoma group (p = 0.004), but not within the mixed/non‐seminomatous group (p = 0.409). The majority of the tested cases (27/28, 96%) exhibited low DVL1 protein expression (median 0%, range 0–90%). In contrast, 20 out of 22 tested cases (91%) exhibited strong expression of DVL2 protein (median 80%, range 0–100%). No significant difference in DVL1 and DVL2 protein expression was observed between seminomas and mixed/non‐seminomatous tumors (p = 0.68 and 0.29). The secreted frizzled‐related protein and disheveled protein family members appear to be actively involved in the pathogenesis of primary testicular germ cell tumors. 相似文献
75.
76.
Eliad Karin Shmuel Avital Iris Dotan Yehuda Skornick Ron Greenberg 《Colorectal disease》2012,14(1):111-114
Aim: The outcome of Doppler‐guided haemorrhoidal artery ligation (DGHAL) was assessed in patients with Crohn’s disease (CD) suffering from grade III haemorrhoids. Method: A retrospective study was carried out of patients with CD and symptomatic Grade III haemorrhoids treated by DGHAL. Perioperative and follow‐up data were retrieved from our database of patients undergoing DGHAL. Results: The study included seven men and six women. The mean age was 34 years old. All had CD without anorectal involvement. The median duration of haemorrhoidal symptoms was 6.3 years. There was no mortality, new incontinence, faecal impaction, urinary retention, abscess formation or persistent pain following the procedure. Mean pain score based on a visual analogue scale (VAS) decreased from 2.4 at 24 h postoperatively to 1.6 on the seventh postoperative day. All patients had completely recovered by the third postoperative day. At 18 months, three (77%) of the patients were asymptomatic and three had recurrent symptoms. Conclusion: Doppler‐guided haemorrhoidal artery ligation is safe and effective in treating Grade III haemorrhoids in patients with CD without rectal involvement. 相似文献
77.
78.
79.
80.